Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TYVASO for Cor pulmonale chronic: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 143 adverse event reports in the FDA FAERS database where TYVASO was used for Cor pulmonale chronic.

Most Reported Side Effects for TYVASO

Side Effect Reports % Deaths Hosp.
Death 124 23.7% 123 7
Dyspnoea 69 13.2% 2 55
Pneumonia 44 8.4% 5 42
Cough 37 7.1% 2 13
Headache 32 6.1% 0 17
Fluid retention 26 5.0% 1 23
Chest pain 22 4.2% 0 15
Dizziness 22 4.2% 0 12
Pulmonary arterial hypertension 21 4.0% 7 14
Anaemia 15 2.9% 0 13
Oxygen saturation decreased 15 2.9% 1 11
Condition aggravated 13 2.5% 1 10
Diarrhoea 13 2.5% 1 7
Fall 13 2.5% 0 11
Fatigue 13 2.5% 1 3

Other Indications for TYVASO

Pulmonary arterial hypertension (273) Product used for unknown indication (56) Pulmonary hypertension (15)

Other Drugs Used for Cor pulmonale chronic

TREPROSTINIL (1,407) AMBRISENTAN (879) MACITENTAN (254) EPOPROSTENOL (239) BOSENTAN\BOSENTAN (238) REMODULIN (220) TRACLEER (101) ILOPROST (65) BOSENTAN (60) VELETRI (43)

Related Pages

TYVASO Full Profile All Cor pulmonale chronic Drugs TYVASO Demographics TYVASO Timeline